|
Patients
|
42 (50%)
|
36 (43%)
|
6 (7%)
| |
|
Stiffness [kPa]
|
11.0 ± 8.6
|
13.2 ± 11.8
|
11.2 ± 11.9
|
n.s.
|
|
APRI score (median, range)
|
2.7 ± 7.1 (0.9; 0.3 - 43.2)
|
1.4 ± 1.2 (0.8; 0.4 - 5.7)
|
1.1 ± 0.6 (1.3; 0.5 - 1]
|
n.s.
|
|
FIB-4 score (median, range)
|
3.8 ± 8.2 (1.6; 0.5 - 50,3)
|
2.2 ± 2.0 (1.5; 0.7 - 10.7)
|
2.2 ± 1.3 (1.6; 0.9 - 3.8)
|
n.s.
|
|
ast [U/I]
|
65 ± 41
|
57 ± 33
|
64 ± 39
|
n.s.
|
|
ALT [U/l]
|
84 ± 52
|
74 ± 47
|
94 ± 87
|
n.s.
|
|
Thrombocytes [T/l]
|
163 ± 77
|
157 ± 5
|
181 ± 55
|
n.s.
|
|
HCV-load
| | | |
n.s.
|
|
Undetectable:
|
9 (21%)
|
5 (14%)
| | |
|
low (< 800000 IU/1)
|
6 (14%)
|
8 (23%)
| | |
|
high (> 800000 1 U/1)
|
27 (64%)
|
22 (63°/.)
|
6 (100%)
| |
|
HCV-genotype
| | | |
p = 0.03
|
|
1
|
20 (54%)
|
29 (88%)
|
3 (60%)
| |
|
2
|
5 (14%)
|
1 (3%)
| | |
|
3
|
10(27%)
|
2 (6%)
|
1 (20%.)
| |
|
4
|
2 (5%)
|
1 (3%)
|
1 (20%)
| |
|
HAART
|
34(81%)
|
31(86%)
|
4(67%)
|
n.s.
|
|
CD4 [cells/μl] (median, range)
|
428 (52 - 1757)
|
366 (10 - 966)
|
268 (85 - 1056)
| |
| |
428 (52 - 1757)
|
356 (10 - 1056)
|
p = 0.02
|
|
< 50 HIV copies/ml
|
35 (83%)
|
23 (64%)
|
4 (67%)
|
n.s.
|
